Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash

Chemical educator and <i>Compound Interest</i> blogger Andy Brunning explains the CBD craze, how the compound works, and how it's regulated.

No, US EPA says in proposal

Draft assessment confirms previous concerns about health effects of chlorinated solvent

Venture will combine six active pharmaceutical ingredient production sites in Europe

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

Colibactin causes key cancer mutations

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Results for 2019 show resilience, but coronavirus impact shadows forecasts for this year

Draft assessment confirms concerns about health effects of chlorinated solvent

Without policy changes, the gap between actual greenhouse gas emission reductions and those needed to hit climate targets will continue to widen

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic

Colibactin causes key cancer mutations

Venture will combine 6 active pharmaceutical ingredient production sites in Europe

Method provides petroleum-free way to turn industrial biowaste into valuable commodity

Shocked to learn how little plastic gets recycled, the duo founded a company so they could make a difference

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers

Barred as a woman from becoming a brewer in India, Mazumdar-Shaw instead founded biotech firm Biocon and today focuses on affordable health care

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle

Her company, Saule Technologies, has a low-cost process to print the solar cells on a multitude of materials

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more

The MIT chemical engineering head is charting a course into the start-up world with LayerBio

Known as Big Sister for her mentorship, Du and her newest firm, Zai Lab, are setting new standards in Asia

Prolific biotech business founder says she's always on the lookout for problem-solving opportunities

Nobel Prize winner wants to solve real-world problems with directed evolution

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

Concerns over the spread of the novel coronavirus leads to decision

Spring lineup of conferences and events frequented by chemists is slashed

Creating more opportunities for dialogue is just the first step

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel

The technique, called MicroMapping, identifies potential protein interactions on and between cells

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19